NRAS c.502A>C ;(p.M168L)

Variant ID: 1-115251224-T-G

NM_002524.4(NRAS):c.502A>C;(p.M168L)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Next-generation sequencing in thyroid cancers: do targetable alterations lead to a therapeutic advantage?: A multicenter experience.

Medicine
Moore, Assaf A; Bar, Yael Y; Maurice-Dror, Corinne C; Finkel, Inbar I; Goldvaser, Hadar H; Dudnik, Elizabeth E; Goldstein, Daniel A DA; Gordon, Noa N; Billan, Salem S; Gutfeld, Orit O; Wolf, Ido I; Popovtzer, Aron A
Publication Date: 2021-06-25

Variant appearance in text: NRAS: M168L
PubMed Link: 34160418
Variant Present in the following documents:
  • Main text
View BVdb publication page